Zephyrnet Logo

Tag: Thrombosis

Top News

FDA Approves Balfaxar (prothrombin complex concentrate, human-lans) for Warfarin Reversal in Urgent Surgery & Invasive Procedures

FDA Approves Balfaxar (prothrombin complex concentrate, human-lans) for Warfarin Reversal in Urgent Surgery & Invasive ProceduresPARAMUS, N.J., July 26, 2023 /PRNewswire/ -- Octapharma USA...

Latest NMPA Device Classifications Released

The NMPA Medical Device Standardization Administration issued the “Second Batch of Medical Device Classification Results for 2023” on July 13. The document identifies 71...

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A

FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia ASAN RAFAEL, Calif., June 29, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:...

Juice concentrate from Japanese fruit benefits cardiovascular health,

(Philadelphia, PA) – More than 122 million Americans – about half of the U.S. population ages 20 and older – have high blood pressure,...

Benefits of Taking Eliquis (Apixaban)

More than 2 million Americans suffer from a condition known as atrial fibrillation, a type of heart rhythm disorder that can lead to a...

Engineered macromolecular Toll-like receptor agents and assemblies

Nakkala J.R. et al.Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases.Acta Biomater. 2021; 123: 1-30Lee D. et al.Harnessing innate immunity using...

DNA-framework-based multidimensional molecular classifiers for cancer diagnosis

Collins, F. S. & Varmus, H. A new initiative on precision medicine. N. Engl. J. Med. 372, 793–795 (2015).Article  CAS  Google Scholar  Thomasian,...

Vortex ultrasound tool breaks down blood clots in the brain

Cerebral venous sinus thrombosis (CVST) is a clot in the veins that drain blood away...

NMPA Recognized Innovative Devices in 2022

The following 32 innovative devices NMPA have been mentioned in 2022 Innovation Approval Notices published by the NMPA. China Med Device, LLC categorized them...

Inari Medical begins subject enrolment in ClotTriever System trial

<!----> Inari Medical has enrolled the first participant in the DEFIANCE trial of its ClotTriever System in iliofemoral...

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

IRVINE, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and...

The Intersection Of Bitcoin And Medical Tourism

This is an opinion editorial by Frankie Wallace, a freelance writer from the Pacific Northwest.Medical tourism is on the rise. Every year millions of...

Latest Intelligence

spot_img
spot_img